Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 6451 AL 6465

Pathophysiological role of high mobility group box-1 signaling in neurodegenerative diseases

Kumar V, Kumar P.

Inflammopharmacology. 2025 Feb;33(2):703-727. doi: 10.1007/s10787-024-01595-9. Epub 2024 Nov 15.

Preserved Thermoregulation in Huntington's Disease: Insights from an Observational Case-Control Study

Simón-Vicente L, Rivadeneyra-Posadas J, Soto-Célix M, Raya-González J, Rodríguez-Fernández A, Castillo-Alvira D, Vázquez F, Cubo E.

Mov Disord Clin Pract. 2025 Nov;12(11):1784-1791. doi: 10.1002/mdc3.70149. Epub 2025 May 29.

AMT-130 gene therapy: a promising disease-modifying approach for Huntington's disease

Mwape C, Qureshi AA, Saeed MZ, Fatima A, Jamil A, Mahmood H, Batool A, Khan AM.

Ann Med Surg (Lond). 2025 Dec 10;88(1):1144-1145. doi: 10.1097/MS9.0000000000004574. eCollection 2026 Jan.

Berberine can be a Potential Therapeutic Agent in Treatment of Huntington's Disease: A Proposed Mechanistic Insight

Sharma S, Kaur I, Dubey N, Goswami N, Tanwar SS.

Mol Neurobiol. 2025 Nov;62(11):14734-14762. doi: 10.1007/s12035-025-05054-6. Epub 2025 May 16.

Advances in Stem Cell Therapy for Huntington's Disease: A Comprehensive Literature Review

Shah S, Mansour HM, Lucke-Wold B.

Cells. 2025 Jan 3;14(1):42. doi: 10.3390/cells14010042.

Exploring immunotherapeutic strategies for neurodegenerative diseases: a focus on Huntington's disease and Prion diseases

Mukherjee A, Biswas S, Roy I.

Acta Pharmacol Sin. 2025 Jun;46(6):1511-1538. doi: 10.1038/s41401-024-01455-w. Epub 2025 Jan 31.

The Beneficial Effects of Berberine on Brain Functions in Age-Related Neurological Disorders: From Molecular Signaling to Treatment

Wang X, Hou R, Chen Z, Wang X, Malek M, Wang H.

Food Sci Nutr. 2025 Aug 1;13(8):e70563. doi: 10.1002/fsn3.70563. eCollection 2025 Aug.

Natural products in neurodegenerative diseases: recent advances and future outlook

Nahar L, Charoensup R, Kalieva K, Habibi E, Guo M, Wang D, Kvasnica M, Onder A, Sarker SD.

Front Pharmacol. 2025 Mar 19;16:1529194. doi: 10.3389/fphar.2025.1529194. eCollection 2025.

Autoimmune neuropsychiatric sequelae of group A streptococcal infections in Aboriginal and Torres Strait Islander people: an overlooked burden?

Ketheesan S, Wade V, Hung TY, Roberts KV.

Australas Psychiatry. 2025 Aug;33(4):619-622. doi: 10.1177/10398562251351462. Epub 2025 Jun 17.

Arbutin's Potential in Neuroprotection: A Promising Role in Mitigating Neurodegenerative Diseases

Sharma A, Kakkar A, Khanna M, Devi S.

Curr Drug Res Rev. 2025;17(3):343-351. doi: 10.2174/0125899775298987240528050110.

Optical Coherence Tomography in Huntington's Disease-A Potential Future Biomarker for Neurodegeneration?

Cerejo C, De Cleene N, Mandler E, Schwarzová K, Labrecque S, Mahlknecht P, Krismer F, Djamshidian A, Seppi K, Heim B.

Neurol Int. 2025 Jan 20;17(1):13. doi: 10.3390/neurolint17010013.

A critical review on neurodegenerative biomarker diagnostics: where is the field heading to?

Amiri M, Afshary H, Bezaatpour A, Hatamikia S, Wei J, Boukherroub R, Szunerits S.

Anal Bioanal Chem. 2025 Oct;417(24):5435-5448. doi: 10.1007/s00216-025-06061-1. Epub 2025 Oct 7.

Phase II trial of intravenous human dental pulp stem cell therapy for Huntington's disease: a randomized, double-blind, placebo-controlled study

Fernandes JMS, Pagani E, Wenceslau CV, Ynoue LH, Ferrara L, Kerkis I.

Stem Cell Res Ther. 2025 Aug 6;16(1):432. doi: 10.1186/s13287-025-04557-2.

Efficacy of aripiprazole in pediatric-onset Huntington's disease: a case report and literature review

Wang F, Shi R, Xu X.

Neurol Sci. 2025 Dec;46(12):6357-6364. doi: 10.1007/s10072-025-08480-5. Epub 2025 Sep 18.

Protein misfolding and neurodegeneration: Mechanisms, implications, and therapeutic strategies

Shah A, Karthikeyan T, Hashem S, Kumar R, Bhat AA, Macha MA.

Adv Protein Chem Struct Biol. 2025;148:135-177. doi: 10.1016/bs.apcsb.2025.08.012. Epub 2025 Sep 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias